Therapeutic drug monitoring of telaprevir in chronic hepatitis C patients receiving telaprevir -based triple therapy is useful for predicting virological response.
Phase of Trial: Phase I
Latest Information Update: 03 Oct 2013
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Pharmacokinetics
- 22 Jan 2013 The UMIN record reported the study results although it was stated the results are unpublished.
- 22 Jan 2013 New trial record